Search
for
Sort by
Research 871–900 of 1000+
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Systematic Literature Review on Troubleshooting Delivery of Production Product Using n-Vehicle with Vogel Total Difference Approach Method
- Standardization and Validation of Scalp Surface Area Measurement and Assessment of Interchangeability Between Two Independent Methodologies for Head Crown Area and Total Hair Count Measurement
- Possible relationship between chronic telogen effluvium and changes in lead, cadmium, zinc, and iron total blood levels in females: A case-control study
- Tralokinumab Treatment in Adult Atopic Dermatitis Patients: 28‐Week Evaluation of Clinical Effectiveness, Safety, Serum Proteins and Total IgE Levels
- Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Macrocytosis and pseudoalbinism: Manifestations of selenium deficiency
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- 1,25-dihydroxyvitamin D resistance, rickets, and alopecia
- PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years' experience at St John's Institute of Dermatology
- Iron status in diffuse telogen hair loss among women.
- Androgen excess: Investigations and management
- Diagnosis of hyperandrogenism: Biochemical criteria
- Selenium Toxicity: A Case of Selenosis Caused by a Nutritional Supplement
- Semen Parameters Among Transgender Women With a History of Hormonal Treatment
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Androgens in women
- Liver and Kidney Dysfunction in Wistar Rats Exposed to Municipal Landfill Leachate
- Use of topical minoxidil in the treatment of male pattern baldness
- Case Report Vitamin A Toxicity and Hypercalcemia
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Biotin deficiency complicating parenteral alimentation: Diagnosis, metabolic repercussions, and treatment
- Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients